The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.

<h4>Objective and design</h4>We examined the role of eCIRP in the pathogenesis of bleomycin-induced pulmonary fibrosis (PF).<h4>Material and methods</h4>Publicly available gene expression omnibus datasets were analyzed for the expression of CIRP in lung samples from patients...

Full description

Bibliographic Details
Main Authors: Siavash Bolourani, Ezgi Sari, Max Brenner, Ping Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0266163
_version_ 1818239310507278336
author Siavash Bolourani
Ezgi Sari
Max Brenner
Ping Wang
author_facet Siavash Bolourani
Ezgi Sari
Max Brenner
Ping Wang
author_sort Siavash Bolourani
collection DOAJ
description <h4>Objective and design</h4>We examined the role of eCIRP in the pathogenesis of bleomycin-induced pulmonary fibrosis (PF).<h4>Material and methods</h4>Publicly available gene expression omnibus datasets were analyzed for the expression of CIRP in lung samples from patients with PF. Wild type (WT) or CIRP-/- mice received daily injections of 10 μg/g bleomycin for 10 days. A subset of bleomycin-injected WT mice was treated with the eCIRP antagonist C23 (8 μg/g/day) from day 10 to day 19. At three weeks, transthoracic echocardiography was performed to measure the degree of pulmonary hypertension, and lung tissues were collected and analyzed for markers of fibrosis.<h4>Results</h4>Analysis of the mRNA data of human lung samples showed a significant positive correlation between CIRP and α-smooth muscle actin (α-SMA), an important marker of fibrosis. Moreover, the expression of CIRP was higher in patients with acute exacerbation of PF than in patients with stable PF. CIRP-/- mice showed attenuated induction of α-SMA and collagens (Col1a1, Col3a1), reduced hydroxyproline content, decreased histological fibrosis scores, and improved pulmonary hypertension as compared to WT mice. WT mice treated with C23 also had significant attenuation of the above endpoint measure.<h4>Conclusions</h4>Our study demonstrates that eCIRP plays a key role in promoting the development of PF, and blocking eCIRP with C23 can significantly attenuate this process.
first_indexed 2024-12-12T12:55:31Z
format Article
id doaj.art-a20aac2ee5c34d7399514bc8003ca677
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-12T12:55:31Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-a20aac2ee5c34d7399514bc8003ca6772022-12-22T00:23:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01174e026616310.1371/journal.pone.0266163The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.Siavash BolouraniEzgi SariMax BrennerPing Wang<h4>Objective and design</h4>We examined the role of eCIRP in the pathogenesis of bleomycin-induced pulmonary fibrosis (PF).<h4>Material and methods</h4>Publicly available gene expression omnibus datasets were analyzed for the expression of CIRP in lung samples from patients with PF. Wild type (WT) or CIRP-/- mice received daily injections of 10 μg/g bleomycin for 10 days. A subset of bleomycin-injected WT mice was treated with the eCIRP antagonist C23 (8 μg/g/day) from day 10 to day 19. At three weeks, transthoracic echocardiography was performed to measure the degree of pulmonary hypertension, and lung tissues were collected and analyzed for markers of fibrosis.<h4>Results</h4>Analysis of the mRNA data of human lung samples showed a significant positive correlation between CIRP and α-smooth muscle actin (α-SMA), an important marker of fibrosis. Moreover, the expression of CIRP was higher in patients with acute exacerbation of PF than in patients with stable PF. CIRP-/- mice showed attenuated induction of α-SMA and collagens (Col1a1, Col3a1), reduced hydroxyproline content, decreased histological fibrosis scores, and improved pulmonary hypertension as compared to WT mice. WT mice treated with C23 also had significant attenuation of the above endpoint measure.<h4>Conclusions</h4>Our study demonstrates that eCIRP plays a key role in promoting the development of PF, and blocking eCIRP with C23 can significantly attenuate this process.https://doi.org/10.1371/journal.pone.0266163
spellingShingle Siavash Bolourani
Ezgi Sari
Max Brenner
Ping Wang
The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
PLoS ONE
title The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
title_full The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
title_fullStr The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
title_full_unstemmed The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
title_short The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
title_sort role of ecirp in bleomycin induced pulmonary fibrosis in mice
url https://doi.org/10.1371/journal.pone.0266163
work_keys_str_mv AT siavashbolourani theroleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT ezgisari theroleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT maxbrenner theroleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT pingwang theroleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT siavashbolourani roleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT ezgisari roleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT maxbrenner roleofecirpinbleomycininducedpulmonaryfibrosisinmice
AT pingwang roleofecirpinbleomycininducedpulmonaryfibrosisinmice